The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Doxepin Hydrochloride
Doxepn Hydrochloride · DOXEPIN HYDROCHLORIDE 100 mg/1 · Capsule · Oral · Appco Pharma LLC
NDC 55801-0531-01 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Appco Pharma LlcUnited Statesanalysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA214908
- TE code
- AB
- Approval date
- Apr 1, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Doxepn Hydrochloride (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Appco Pharma LLC | DOXEPIN HYDROCHLORIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Doxepin Hydrochloride — NDC 55801-0531-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55801053101.
Free to cite with attribution — see how the data is put together.